Error: Could not add to watchlist. X

Nivalis Therapeutics Inc

+ Watchlist
NVLS:US
NASDAQ GM
14.42
USD
0.12
0.83%
As of 20:10:00 ET on 09/01/2015.
Open
14.30
Day Range
13.70 - 14.66
Volume
60,373
Previous Close
14.54
52Wk Range
13.70 - 20.43
Open
14.30
Day Range
13.70 - 14.66
Volume
60,373
Previous Close
14.54
52Wk Range
13.70 - 20.43
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (m USD)
222.815
Shares Outstanding (m)
15.452
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Nivalis Therapeutics, Inc. operates as a clinical stage pharmaceutical company. The Company focuses on developing a portfolio of small molecule therapeutics for the treatment of major diseases such as cystic fibrosis, asthma, chronic obstructive pulmonary disease, inflammatory bowel disease, and certain cardiovascular disorders.
ADDRESS
3122 Sterling Circle
Suite 200
Boulder, CO 80301
United States
PHONE
1-720-945-7700
  • Jon Congleton
    President/CEO
  • R Michael Carruthers
    CFO/Secretary
  • Janice M Troha
    Chief Operating Officer
  • Steven A Shoemaker
    VP:Clinical Research
  • Sherif Gabriel
    VP:Research
Show More